mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.3 |
mRNA |
ouabain |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.3 |
mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.3 |
mRNA |
BRD-K99006945 |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.3 |
mRNA |
BRD-K48477130 |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.3 |
mRNA |
BRD-K01737880 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.3 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.3 |
mRNA |
BRD-K49290616 |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.3 |
mRNA |
skepinone-L |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.3 |
mRNA |
BRD-K79669418 |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.3 |